Universal Health Services Inc (UHS) Return on Equity ROE from the second quarter 2026 to second quarter 2025 and annually, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Universal Health Services Inc   (NYSE: UHS)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare

Universal Health Services Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Universal Health Services Inc in the second quarter 2026?
Universal Health Services Inc achieved a return on average equity (ROE) of 20.89 % in its second quarter 2026, this is above UHS's average return on equity of 16.39%.
Universal Health Services Inc s equity during the 12 months ending in the second quarter 2026 are valued at $7 billion

ROE fell compared to the first quarter 2026, despite the net income growth of 1.65% from the first quarter 2026.

Within the Healthcare Facilities industry 7 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 579 to 622.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Equity Change 7 % 9.58 % 8.73 % 8.22 % -
Y / Y Net Income Change 0.55 % 11.52 % 32.87 % 42.57 % 23.2 %
Net Income (TTM) in Millions 1,550 1,548 1,511 1,400 1,287
Return On Equity (TTM) 20.89 % 21.22 % 21.19 % 20.05 % 18.8 %
UHS's Total Ranking # 622 # 579 # 488 # 610 #
Equity (TTM) in Millions 7,582 7,531 7,339 7,230 7,086
Seq. Equity Change 0.67 % 2.62 % 1.5 % 2.05 % 3.1 %
Seq. Net Income Change 1.65 % -19.91 % 18.13 % 4.55 % 12.74 %

Back to UHS Management Effectiveness >> UHS's 5 Years Annual ROE >> Compare UHS ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 8
Sector # 80
Overall # 622

Return On Equity Statistics
High Average Low
21.22 %
16.39 %
11.05 %
(Mar 31 2026)   (Sep 30 2023)





UHS Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions 7,339 6,750 6,197 5,965 6,193
Y / Y Equity Change 8.73 % 8.92 % 3.88 % -3.68 % -3.26 %
Net Income in Millions 1,511 1,163 719 657 988
Y / Y Net Income Change 29.93 % 61.7 % 9.49 % -33.48 % 3.66 %
Return On Equity 20.59 % 17.23 % 11.61 % 11.01 % 15.95 %

Back to UHS Management Effectiveness >> UHS's 5 Years Annual ROE >> Compare UHS ROE to its Competitors




Annual Roe Comment
In 2025 ROE improved to 20.59 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Healthcare Facilities Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
UHS's' Return on Equity at Yahoo Finance
UHS's Roe Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for UHS's Competitors
Subscribers only: Roe for Universal Health Services Inc 's Suppliers
Subscribers only: Return On Equity for UHS's Customers




Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector ROE
Vaxart Inc   53.04 %
Qhslab Inc   51.21 %
Tenet Healthcare Corp  50.64 %
Nrc Health  48.29 %
Concentra Group Holdings Parent Inc   48.13 %
Bristol myers Squibb Company  46.65 %
Agilent Technologies inc   41.99 %
Eton Pharmaceuticals Inc   40.13 %
Adma Biologics Inc   39.59 %
Dexcom Inc   36.25 %
Transmedics Group Inc   33.37 %
Arcutis Biotherapeutics Inc   32.92 %
Caredx Inc   32.81 %
Zevra Therapeutics Inc   32.56 %
Acadia Pharmaceuticals Inc   32.39 %
Pro dex Inc   31.96 %
Protalix Biotherapeutics inc   31.61 %
Illumina Inc   31.08 %
Innoviva Inc   30.03 %
Phibro Animal Health Corporation  29.66 %
Chemed Corporation  29.45 %
Solventum Corporation  28.96 %
Pacs Group Inc   27.00 %
Sotera Health Company  26.75 %
Insulet Corporation  26.69 %
Bioventus Inc   25.96 %
Johnson and Johnson  25.74 %
Encompass Health Corporation  25.52 %
Resmed Inc   24.21 %
Healthcare Services Group Inc   24.12 %

Date modified: 2026-09-12T06:14:28+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.